Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro.
The Versatile Mutational Resistome of Pseudomonas aeruginosa.
gyrA
Epidemiology and antimicrobial resistance of pathogens in pediatric sinus infections: a retrospective study at a Japanese otolaryngology clinic (2023-2025).
Mutations in gyrA were associated with reduced susceptibility to levofloxacin in H. influenzae isolates.
A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
The presence of Asp82Gly or Gly81Asp alone led to low-level resistance to fluoroquinolones but not to nalidixic acid resistance. When both mutations were present, resistance to both nalidixic acid and fluoroquinolones was expressed.
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Mutations in the quinolone resistance-determining region (QRDR) of gyrA were associated with resistance to quinolones.
Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in Elizabethkingia anophelis.
The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity.
gyrA
Burkholderia dolosa gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3004860
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
gyrA
G81D mutation confers resistance to ciprofloxacin only. If G81D and D82G are present simultaneously, there is also nalidixic acid resistance
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.
gyrA
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
G81D mutation confers resistance to ciprofloxacin only. If G81D and D82G are present simultaneously, there is also nalidixic acid resistance
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research